FAUTI; TANJA

Patent Applications and Registrations

Patent applications and USPTO patent grants for FAUTI; TANJA.The latest application filed is for "antibodies binding to gprc5d".

Company Profile

9.6.32

FAUTI; TANJA - Zuerich CH
Fauti; Tanja - Zurich CH
FAUTI; Tanja - Schlieren CH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antibodies Binding To Gprc5d App 20220259318 - BUJOTZEK; ALEXANDER ; et al.	2022-08-18
Novel Icos Antibodies And Tumor-targeted Antigen Binding Molecules Comprising Them App 20220098305 - DENGL; Stefan ; et al.	2022-03-31
Antibodies binding to HLA-A2/MAGE-A4 App 20210230278 - Weinzierl; Tina ; et al.	2021-07-29
Method For The Selection Of Antibodies Against Bcma App 20210070873 - VU; Minh Diem ; et al.	2021-03-11
Method for the selection of antibodies against BCMA Grant 10,851,171 - Vu , et al. December 1, 2	2020-12-01
Bispecific T Cell Activating Antigen Binding Molecules App 20200347147 - BACAC; Marina ; et al.	2020-11-05
Combination Therapy Of Tumor Targeted Icos Agonists With T-cell Bispecific Molecules App 20200306373 - BACAC; Marina ; et al.	2020-10-01
Bispecific T cell activating antigen binding molecules Grant 10,766,967 - Bacac , et al. Sep	2020-09-08
Bispecific Antibodies Against Cd3epsilon And Ror1 App 20200255521 - Kind Code	2020-08-13
Tumor-targeted Agonistic Cd28 Antigen Binding Molecules App 20200199234 - GEORGES; Guy ; et al.	2020-06-25
Bispecific antibodies against CD3 and BCMA Grant 10,253,104 - Vu , et al.	2019-04-09
Fc-free antibodies comprising two fab-fragments and methods of use Grant 10,087,250 - Bruenker , et al. October 2, 2	2018-10-02
Bispecific T Cell Activating Antigen Binding Molecules App 20180273643 - AST; Oliver ; et al.	2018-09-27
Bispecific antibodies against CD3 and BCMA Grant 10,077,315 - Vu , et al. September 18, 2	2018-09-18
Method For The Selection Of Antibodies Against Bcma App 20180222991 - VU; Minh Diem ; et al.	2018-08-09
Method for the selection of antibodies against BCMA Grant 9,963,513 - Vu , et al. May 8, 2	2018-05-08
Bispecific Antibodies Against Cd3epsilon And Bcma App 20170327579 - VU; MINH DIEM ; et al.	2017-11-16
Bispecific Antibodies Against Cd3epsilon And Bcma App 20170306036 - VU; Minh Diem ; et al.	2017-10-26
Bispecific Antibodies Against Cd3epsilon And Ror1 For Use In The Treatment Of Ovarian Cancer App 20170306044 - VU; MINH DIEM ; et al.	2017-10-26
Bispecific Antibodies Against Cd3epsilon And Ror1 App 20170306018 - VU; MINH DIEM ; et al.	2017-10-26
Bispecific Antigen Binding Molecules App 20170198043 - Auer; Johannes ; et al.	2017-07-13
Bispecific T Cell Activating Antigen Binding Molecules App 20170190783 - Bacac; Marina ; et al.	2017-07-06
Bispecific T cell activating antigen binding molecules App 20170114146 - Klein; Christian ; et al.	2017-04-27
Bispecific T Cell Activating Antigen Binding Molecules App 20170096485 - BACAC; Marina ; et al.	2017-04-06
BISPECIFIC ANTIBODIES AGAINST CD3EPSILON and ROR1 App 20160297881 - VU; Minh Diem ; et al.	2016-10-13
Fc-free antibodies comprising two Fab-fragments and methods of use App 20160130347 - Bruenker; Peter ; et al.	2016-05-12
Bispecific Antibodies Against Cd3 And Bcma App 20150376287 - VU; Minh Diem ; et al.	2015-12-31
Method For The Selection Of Antibodies Against Bcma App 20150368351 - VU; Minh Diem ; et al.	2015-12-24
Bispecific Antibodies Specific For T-cell Activating Antigens And A Tumor Antigen And Methods Of Use App 20150274845 - Bruenker; Peter ; et al.	2015-10-01
Bispecific T Cell Activating Antigen Binding Molecules App 20130078249 - Ast; Oliver ; et al.	2013-03-28
Bispecific T Cell Activating Antigen Binding Molecules App 20130078250 - Ast; Oliver ; et al.	2013-03-28
Bispecific antigen binding molecules App 20130058937 - Auer; Johannes ; et al.	2013-03-07
Bispecific Antibodies Specific For T-cell Activating Antigens And A Tumor Antigen And Methods Of Use App 20130058936 - Bruenker; Peter ; et al.	2013-03-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.